March 4, 2020
The Japan unit of GE Healthcare Pharma said on March 2 that it took over on the same day the Japanese marketing authorization for four imaging agents, including the nonionic X-ray contrast agent Omnipaque (iohexol), from Daiichi Sankyo. The four...read more